ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
omnisearch
|
664 |
271K |
27 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
664
|
271K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
omnisearch
|
716 |
203K |
18 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
716
|
203K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
omnisearch
|
716 |
203K |
70 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
716
|
203K
|
70
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast CC Transcript 31/8
|
|
omnisearch
|
73 |
30K |
40 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
73
|
30K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
omnisearch
|
1.0K |
399K |
148 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
148
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP
|
|
omnisearch
|
144 |
66K |
28 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
66K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
DREAM HF Trial Video
|
|
omnisearch
|
99 |
34K |
50 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
99
|
34K
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
omnisearch
|
484 |
147K |
33 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
484
|
147K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
omnisearch
|
1.6K |
464K |
55 |
22/05/21 |
22/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
omnisearch
|
1.6K |
464K |
85 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
85
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
omnisearch
|
1.0K |
517K |
54 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.0K
|
517K
|
54
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
omnisearch
|
10K |
3.0M |
50 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
omnisearch
|
576 |
234K |
7 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
576
|
234K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
omnisearch
|
1.0K |
517K |
8 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
omnisearch
|
1.0K |
517K |
7 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
omnisearch
|
576 |
234K |
66 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
576
|
234K
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
omnisearch
|
576 |
234K |
62 |
06/09/20 |
06/09/20 |
ASX - By Stock
|
576
|
234K
|
62
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
omnisearch
|
17K |
6.7M |
50 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
17K
|
6.7M
|
50
|
|
ASX - By Stock
|
MSB |
Re:
$MESO Started Phase 2/3 Covid ARDS trial 3 days ago with 6 locations now expanded to 14!
|
|
omnisearch
|
87 |
48K |
14 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
87
|
48K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
omnisearch
|
17K |
6.7M |
18 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
18
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
omnisearch
|
23K |
13M |
26 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
23K
|
13M
|
26
|
|